$MDXG Q3 '26 Earnings Results & Recap
• Reported GAAP EPS of -$0.01 down -106.67% YoY
• Reported revenue of $62.28M down -45.23% YoY
• MiMedx expects 2026 net sales of $250 to $260M, fourth-quarter Adjusted EBITDA sequentially higher than the third quarter, and longer-term annual net sales growth in the low double-digits with adjusted EBITDA margin above 20%.